Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome
- 682 Downloads
The study of the detailed molecular history of cancer development is one of the most promising techniques to understand and fight this diverse and prevalent disease. Unfortunately, this history is as diverse as cancer itself. Therefore, even with next-generation sequencing techniques, it is not easy to distinguish significant (driver) from random (passenger) events. The International Cancer Genome Consortium (ICGC) was formed to solve this fundamental issue by coordinating the sequencing of samples from 50 different cancer types and/or sub-types that are of clinical and societal importance. The contribution of Spain in this consortium has been focused on chronic lymphocytic leukemia (CLL). This approach has unveiled new and unexpected events in the development of CLL. In this review, we introduce the approaches utilized by the consortium for the study of the CLL genome and discuss the recent results and future perspectives of this work.
KeywordsChronic lymphocytic leukemia Cancer genome Next-generation sequencing
This work was funded by the Spanish Ministry of Economy and Competitiveness through the Instituto de Salud Carlos III (ISCIII) and Red Temática de Investigación del Cáncer (RTICC) del ISCIII. We are very grateful to all members of the Spanish CLL Genome Consortium for their continuous support and collaboration. We are also very grateful to all patients with CLL who have participated in this study.
- 19.Network CGAR (2011) Integrated genomic analyses of ovarian carcinoma. Nature 7353:609–615Google Scholar
- 21.Quesada V, Conde L, Villamor N et al (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 1:47–52Google Scholar
- 25.Zenz T, Mertens D, Kuppers R et al (2010) From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 1:37–50Google Scholar
- 26.Hamblin TJ, Davis Z, Gardiner A et al (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 6:1848–1854Google Scholar
- 49.Graubert TA, Shen D, Ding L et al (2012) Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat Genet 1:53–57Google Scholar
- 55.Bulwin GC, Heinemann T, Bugge V et al (2006) TIRC7 inhibits T cell proliferation by modulation of CTLA-4 expression. J Immunol 10:6833–6841Google Scholar
- 62.Grenard P, Bates MK, Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase Z. J Biol Chem 35:33066–33078CrossRefGoogle Scholar
- 66.Leary RJ, Kinde I, Diehl F et al (2010) Development of personalized tumor biomarkers using massively parallel sequencing. Sci Transl Med 20:20ra14Google Scholar